Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

Dutasteride may help reduce brain inflammation and improve cognition.

Estrogen helps prevent artery plaque by stopping monocyte capture in blood vessels.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

A new compound may effectively inhibit the enzyme linked to BPH and hair loss.

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.

A nano-formula of quercetin effectively improves heart health in metabolic syndrome.

Clascoterone safely promotes hair growth similar to minoxidil.

New acne treatments like clascoterone and minocycline foam are effective, and using antibiotics carefully is important to avoid resistance.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Oral retinoids are effective for severe skin conditions but require careful use due to side effects.

Simvastatin and Luteolin effectively reduce hair loss and promote hair growth.

St. John's Wort may reduce the effectiveness of finasteride by increasing its breakdown in the body.

Cedrol may help reduce liver fat and fat cell growth caused by corticosteroids.

Four new cases of gynecomastia (male breast enlargement) linked to finasteride (Propecia) have been found.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Taking 1mg finasteride tablets for 6 months can lower good cholesterol (HDL) and raise triglycerides in men with hair loss.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Both finasteride and drospirenone treatments improved symptoms and increased pregnancy rates in women with polycystic ovary syndrome.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

Diane and Androcur 10 improved acne and seborrhea in most women, and hirsutism and alopecia in about half.

Antiretrovirals can affect finasteride's effectiveness, so dose adjustments may be needed for men on HIV treatment.